Also standing room only at RDUS presentation @ Cowen Healthcare Conference presentation. Institutions must see a very favorable reward-to-risk here. CEO also had a host of investor meetings.
"it could drop below $50" ???? RDUS looks like $30 ! Quite a drop in one month ! $80 ?????? from your lips to god's ears.....
wow---they knew so much.... had so much insighgt
do you knw anything about anything ??? its always fun watching some loud mouthed know it all---you little beachballbaby----get spanked for you uppity attitude all these years.
it looks like somebody crammed it in to your face, little rookie. Once again you have missed the boat---no surprise there.
OH.....at least one trial is a success ! thanks for the info ! are you related to the chump ceo ?
Way to go rookie ! once again your high brow BS leaves you in the dirt. Are you gonna double up and buy another 50 shares ?? Clink Clink ! will Mommie lose her job now ? who's gonna be your sitter now ?
you WAY TOO FUNNEEE ! once again you have no clue. THLD is on the edge of the cliff & you brag about 25 different trials ????
Should be this week----Kanuma FDA approval today or tomorrow & MAJOR analyst mtg/pipeline review----first time in many years----THIS THURSDAY 12/10 in NYC. Two very nice triggers.
Director Philip Sharp sold 30,000 ALNY @ $109 for $ 3.27 mil----looks like a very smart move !!
The simple fact is that THLD is a speculative play where professional investors have determined to stay away. Should data on one or both trials prove to be positive then investors will pay up.